2.
12例COVID-19患者入院后第2天的实验室检验特征
Laboratory test results of the COVID-19 patients on day two following admission
| Laboratory test results | Normal range | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | Case 12 | Abnormal rate (%) |
| Blood routine | ||||||||||||||
| White blood cell (WBC, 109/L) |
3.5-9.5 | 11.4 | 12.6 | 6.3 | 4.8 | 7.4 | 16.2 | 3.7 | 4.5 | 5.7 | 6 | 5.5 | 4.1 | 25 |
| Neutrophil ratio (NER, %) |
50-70 | 89.6 | 78.4 | 51 | 48.8 | 74.3 | 92.6 | 61 | 27.9 | 59.6 | 58.2 | 53.6 | 50.1 | 50 |
| Lymphocyte ratio (LYR, %) |
20-40 | 8.3 | 15.1 | 36 | 38.4 | 17.1 | 1.3 | 24 | 60 | 27.5 | 30.3 | 27.4 | 39.2 | 33.3 |
| Monocyte ratio (MOR, %) |
3-8 | 2 | 4.9 | 11.6 | 10.7 | 7.1 | 6 | 14.2 | 8.6 | 11.7 | 8.6 | 16.1 | 8.8 | 75 |
| Platelet (PLT, 109/L) |
125-350 | 310 | 246 | 367 | 254 | 268 | 133 | 117 | 239 | 273 | 288 | 247 | 188 | 16.7 |
| Hemoglobin (HGB, g/L) |
130-175 (Male) 115-150 (Female) |
107 | 132 | 161 | 156 | 129 | 124 | 162 | 122 | 101 | 143 | 153 | 127 | 33.3 |
| Biochemical indexes of heart, liver, and kidney function | ||||||||||||||
| Serum K (K, mmol/L) |
3.5-5.3 | 3.09 | 3.48 | 3.26 | 4.03 | 3.74 | 3.14 | 3.05 | 3.84 | 3.46 | 4.48 | 3.89 | 3.91 | 50 |
| Serum Na (Na, mmol/L) |
137-147 | 135 | 131 | 138.7 | 139 | 131 | 136 | 136 | 138 | 132 | 139 | 139 | 137 | 50 |
| Glucose (GLU, mmol/L) |
3.89-6.11 | 5.04 | 10.78 | 5.01 | 4.43 | 6.15 | 9.51 | 5.16 | 4.69 | 5.13 | 4.93 | 5.34 | 5.13 | 25 |
| Blood urea nitrogen (BUN, mmol/L) |
2.5-7.14 | 4.29 | 3.36 | 3.22 | 5.11 | 4.09 | 6.94 | 7.07 | 4.91 | 2.55 | 4.25 | 4.15 | 3.05 | 0 |
| Serum creatinine (Scr, µmol/L) |
40-133 | 63.8 | 75.3 | 119.5 | 106.6 | 91.3 | 111.2 | 105.5 | 50.8 | 53.8 | 89.1 | 93.1 | 53.5 | 0 |
| Uric acid (UA, µmol/L) | 150-430 | 220 | 206 | 465 | 356 | 305 | 266 | 468 | 331 | 202 | 284 | 446 | 194 | 25 |
| Albumin (ALB, g/L) |
40-55 | 33.7 | 34.6 | 42.8 | 46.2 | 29.4 | 36 | 34.3 | 36.7 | 39.4 | 43.6 | 39.6 | 35 | 75 |
| Triglyceride (TG, mmol/L) | 0.23-1.71 | 1.05 | 0.95 | 2.43 | 2.22 | 1.7 | 1.07 | 2.58 | 1.3 | 1.37 | 0.97 | 3.3 | 2.15 | 41.7 |
| Cholesterol (CH, mmol/L) | 2.9-5.72 | 5.2 | 3.61 | 4.23 | 4.55 | 5.1 | 4.43 | 4.05 | 5.65 | 4.86 | 4.67 | 4.34 | 4.44 | 0 |
| Total bilirubin (TBIL, µmol/L) | 2-20 | 16.1 | 25.4 | 30.6 | 16.9 | 19.3 | 13.7 | 13 | 19 | 13.6 | 14.7 | 15.7 | 14.1 | 16.7 |
| Glutamic pyruvic transaminase (ALT, U/L) |
9-50 （Male） 7-40 （Female） |
22 | 10 | 34 | 12 | 19 | 21 | 19 | 16 | 12 | 23 | 31 | 16 | 0 |
| Glutamic oxaloacetic transaminase (AST, U/L) |
15-40 （Male） 13-35 （Female） |
32 | 14 | 23 | 18 | 21 | 33 | 17 | 28 | 23 | 22 | 21 | 15 | 0 |
| Creatine kinase (CK, U/L) |
0-174 | 79 | 69 | 71 | 76 | 34 | 373 | 26 | 97 | 58 | 68 | 69 | 35 | 8.3 |
| Lactic dehydrogenase (LDH, U/L) |
100-300 | 332 | 194 | 226 | 193 | 171 | 270 | 199 | 175 | 220 | 149 | 181 | 202 | 8.3 |
| Coagulation function | ||||||||||||||
| Fibrinogen (FIB-C, g/L) |
1.8-4.88 | 5.42 | 2.3 | 2.5 | 3.2 | 8.4 | 5.88 | 4.85 | 2.5 | 3.49 | 1.53 | 2.9 | 2.64 | 25 |
| Plasma d-dimer (D-Dimer, µg/L) |
0-550 | 310 | 150 | 164 | 220 | 1920 | 1470 | 290 | 153 | 2110 | 750 | 320 | 160 | 33.3 |
| Infection indexes | ||||||||||||||
| C-reaction protein (CRP, mg/L) |
0-8 | 74.7 | 29.06 | 19.6 | 5.2 | 113.76 | 124.78 | 33.43 | < 0.499 | 15.3 | 1.14 | 5.61 | 2.99 | 83.3 |
| Procalcitonin (PCT, ng/mL) |
0-0.5 | 0.05 | 0.034 | < 0.1 | < 0.1 | 0.112 | 0.116 | < 0.1 | < 0.02 | < 0.1 | < 0.1 | 0.13 | < 0.1 | 16.7 |